Treatment preferences among individuals with primary hyperoxaluria type 1 (PH1): a real-world study.

Goldfarb DS, Chen JV, Zincavage R, Padilla B, Sussman M, Salem S, Modersitzki F

Open source

DOI
10.1186/s13023-025-03738-9
Published
2025 May 14
Container
Orphanet journal of rare diseases
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s13023-025-03738-9,
  title = {Treatment preferences among individuals with primary hyperoxaluria type 1 (PH1): a real-world study.},
  author = {Goldfarb DS and Chen JV and Zincavage R and Padilla B and Sussman M and Salem S and Modersitzki F},
  year = {2025},
  journal = {Orphanet journal of rare diseases},
  doi = {10.1186/s13023-025-03738-9},
  url = {https://doi.org/10.1186/s13023-025-03738-9}
}

RIS

TY  - JOUR
TI  - Treatment preferences among individuals with primary hyperoxaluria type 1 (PH1): a real-world study.
AU  - Goldfarb DS
AU  - Chen JV
AU  - Zincavage R
AU  - Padilla B
AU  - Sussman M
AU  - Salem S
AU  - Modersitzki F
PY  - 2025
JO  - Orphanet journal of rare diseases
DO  - 10.1186/s13023-025-03738-9
UR  - https://doi.org/10.1186/s13023-025-03738-9
ER  - 

APA

DS, G., JV, C., R, Z., B, P., M, S., S, S., & F, M. (2025). Treatment preferences among individuals with primary hyperoxaluria type 1 (PH1): a real-world study.. Orphanet journal of rare diseases. https://doi.org/10.1186/s13023-025-03738-9

Source records